These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 12833030)

  • 1. An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis.
    Meshkinpour A; Sun J; Weinstein G
    J Am Acad Dermatol; 2003 Jul; 49(1):145-7. PubMed ID: 12833030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-blind, randomized controlled trial evaluating the treatment of facial seborrheic dermatitis with hydrocortisone 1% ointment compared with tacrolimus 0.1% ointment in adults.
    Papp KA; Papp A; Dahmer B; Clark CS
    J Am Acad Dermatol; 2012 Jul; 67(1):e11-5. PubMed ID: 22101215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pimecrolimus cream 1% can be an effective treatment for seborrheic dermatitis of the face and trunk.
    Rallis E; Nasiopoulou A; Kouskoukis C; Koumantaki E
    Drugs Exp Clin Res; 2004; 30(5-6):191-5. PubMed ID: 15700745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open-label efficacy pilot study with pimecrolimus cream 1% in adults with facial seborrhoeic dermatitis infected with HIV.
    de Moraes AP; de Arruda EA; Vitoriano MA; de Moraes Filho MO; Bezerra FA; de Magalhães Holanda E; de Moraes ME
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):596-601. PubMed ID: 17447972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacies of topical agents for the treatment of seborrheic dermatitis of the scalp: a comparative study.
    Shin H; Kwon OS; Won CH; Kim BJ; Lee YW; Choe YB; Ahn KJ; Eun HC
    J Dermatol; 2009 Mar; 36(3):131-7. PubMed ID: 19335686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrolimus ointment 0.1% in the treatment of allergic contact eyelid dermatitis.
    Katsarou A; Armenaka M; Vosynioti V; Lagogianni E; Kalogeromitros D; Katsambas A
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):382-7. PubMed ID: 19207676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus 0.1% ointment for seborrhoeic dermatitis: an open-label pilot study.
    Braza TJ; DiCarlo JB; Soon SL; McCall CO
    Br J Dermatol; 2003 Jun; 148(6):1242-4. PubMed ID: 12828755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients.
    Reitamo S; Rustin M; Harper J; Kalimo K; Rubins A; Cambazard F; Brenninkmeijer EE; Smith C; Berth-Jones J; Ruzicka T; Sharpe G; Taieb A;
    Br J Dermatol; 2008 Sep; 159(4):942-51. PubMed ID: 18637898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical pimecrolimus in the treatment of seborrheic dermatitis.
    Brownell I; Quan LT; Hsu S
    Dermatol Online J; 2003 Aug; 9(3):13. PubMed ID: 12952760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
    Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus.
    Naylor M; Elmets C; Jaracz E; Rico JM
    J Dermatolog Treat; 2005 Aug; 16(3):149-53. PubMed ID: 16096180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.
    Remitz A; Harper J; Rustin M; Goldschmidt WF; Palatsi R; van der Valk PG; Sharpe G; Smith CH; Dobozy A; Turjanmaa K;
    Acta Derm Venereol; 2007; 87(1):54-61. PubMed ID: 17225017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.
    Warshaw EM; Wohlhuter RJ; Liu A; Zeller SA; Wenner RA; Bowers S; Schultz JC; Katz HI; McCormick CL; Parneix-Spake A
    J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical tacrolimus treatment for chronic dermatitis of the ear.
    Harth W; Caffier PP; Mayelzadeh B; Haupt H; Sedlmaier B; Richard G
    Eur J Dermatol; 2007; 17(5):405-11. PubMed ID: 17673384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of seborrheic dermatitis: the efficiency of sertaconazole 2% cream vs. tacrolimus 0.03% cream.
    Goldust M; Rezaee E; Raghifar R; Hemayat S
    Ann Parasitol; 2013; 59(2):73-7. PubMed ID: 24171300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
    Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
    Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
    J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
    Wollenberg A; Reitamo S; Atzori F; Lahfa M; Ruzicka T; Healy E; Giannetti A; Bieber T; Vyas J; Deleuran M;
    Allergy; 2008 Jun; 63(6):742-50. PubMed ID: 18445188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
    Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
    Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.